BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3548261)

  • 1. Blood pressure effects of apomorphine and domperidone in parkinsonism.
    Pollak P; Mallaret M; Gaio JM; Hommel M; Perret J
    Adv Neurol; 1987; 45():263-6. PubMed ID: 3548261
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toloxatone, parkinsonism and dopa therapy].
    Cantagrel A; Dordain G; Dostert P
    Therapie; 1986; 41(6):493-7. PubMed ID: 3810545
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of apomorphine in clinical practice.
    MacMahon DG
    Adv Neurol; 1999; 80():529-33. PubMed ID: 10410767
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of apomorphine on the bladder of parkinsonian patients].
    Aranda B; Cramer P; Adba MA
    J Urol (Paris); 1992; 98(1):25-9. PubMed ID: 1527394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia.
    Narabayashi H; Kondo T; Yokochi F; Nagatsu T
    Adv Neurol; 1987; 45():593-602. PubMed ID: 3103397
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease.
    Schoffer KL; Henderson RD; O'Maley K; O'Sullivan JD
    Mov Disord; 2007 Aug; 22(11):1543-9. PubMed ID: 17557339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].
    Miranda M; Saéz D
    Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy-Drager syndrome).
    West JN; Stallard TJ; Dimmitt SB; Smith SA; Williams A; Littler WA
    Q J Med; 1990 Feb; 74(274):209-13. PubMed ID: 1971724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
    Olanow CW; Alberts MJ
    Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].
    Senda Y; Muto T; Matsuoka Y; Takahashi A; Sobue I
    Rinsho Shinkeigaku; 1987 Mar; 27(3):300-4. PubMed ID: 3111772
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J; Fischer R
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract]   [Full Text] [Related]  

  • 12. Parallel double-blind study of pergolide in Parkinson's disease.
    Jankovic J; Orman J
    Adv Neurol; 1987; 45():551-4. PubMed ID: 3548265
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of orthostatic dysregulation: dihydroergotamine and etilefrin as a combination compared to the monosubtances].
    Polzien P; Bracharz H
    Med Klin; 1980 Dec; 75(25):878-82. PubMed ID: 6110162
    [No Abstract]   [Full Text] [Related]  

  • 14. [Orthostatic dysregulation in Parkinson syndrome. Results of a study of 250 patients].
    Briebach T; Baas H; Fischer PA
    Nervenarzt; 1990 Aug; 61(8):491-4. PubMed ID: 2234225
    [No Abstract]   [Full Text] [Related]  

  • 15. Actions of dopaminergic agonists in parkinsonism.
    McDowell FH; Sweet R
    Adv Neurol; 1975; 9():367-71. PubMed ID: 1096573
    [No Abstract]   [Full Text] [Related]  

  • 16. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.
    Schirger A; Sheps SG; Thomas JE; Fealey RD
    Mayo Clin Proc; 1981 Jul; 56(7):429-33. PubMed ID: 6166817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apomorphine for treatment of "off-periods" in Parkinson's disease].
    Zoldan J; Merims D; Kuritzky A; Ziv I; Melamed E
    Harefuah; 1999 Nov; 137(10):444-6, 512, 511. PubMed ID: 10959339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin and propranolol combined treatment for Shy-Drager syndrome.
    Galassi G
    J Neurol Neurosurg Psychiatry; 1982 May; 45(5):472-3. PubMed ID: 7086460
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of dihydroergotamine in the prevention and treatment of orthostatic hypotension syndromes in patients with parkinsonism treated with L-dopa].
    Jubert Gruart J; Balcells Riba M
    Arch Neurobiol (Madr); 1974; 37(4):401-12. PubMed ID: 4433212
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis and treatment of Shy-Drager syndrome].
    Gubskiĭ LV
    Sov Med; 1989; (6):115-7. PubMed ID: 2799483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.